“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: Gene therapy for β-thalassemia and sickle cell disease in Europe and the United States

€3.03

SKU: product-article-44937 Category: General

Description
Reviews (0)

Description

Gene therapy for β-thalassemia and sickle cell disease in Europe and the United States

Reviews

There are no reviews yet.

Be the first to review “Article: Gene therapy for β-thalassemia and sickle cell disease in Europe and the United States”

You must be logged in to post a review.

Top

Article: Gene therapy for β-thalassemia and sickle cell disease in Europe and the United States

Description

Reviews

Related products

Article: Highlights in urologic cancer

Article: Highlights in genitourinary cancers

Article: Highlights in breast cancer

Article: Highlights in digestive oncology